LOCAL-DELIVERY OF VASCULAR ENDOTHELIAL GROWTH-FACTOR ACCELERATES REENDOTHELIALIZATION AND ATTENUATES INTIMAL HYPERPLASIA IN BALLOON-INJURED RAT CAROTID-ARTERY

被引:454
作者
ASAHARA, T
BAUTERS, C
PASTORE, C
KEARNEY, M
ROSSOW, S
BUNTING, S
FERRARA, N
SYMES, JF
ISNER, JM
机构
[1] TUFTS UNIV,SCH MED,ST ELIZABETH MED CTR,DEPT MED CARDIOL,BOSTON,MA 02135
[2] GENENTECH INC,DEPT CARDIOVASC RES,S SAN FRANCISCO,CA 94080
[3] TUFTS UNIV,SCH MED,ST ELIZABETH MED CTR,DEPT CARDIOVASC SURG,BOSTON,MA 02135
[4] TUFTS UNIV,SCH MED,ST ELIZABETH MED CTR,DEPT BIOMED RES,BOSTON,MA 02135
关键词
GROWTH FACTORS; ENDOTHELIUM; NEOINTIMA; STENOSIS;
D O I
10.1161/01.CIR.91.11.2793
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Most strategies designed to reduce restenosis by the use of pharmacological or biological reagents involve direct inhibition of vascular smooth muscle cell (SMC) proliferation. Alternatively, SMC proliferation might be indirectly inhibited if reendothelialization could be specifically facilitated at sites of balloon-induced arterial injury. Accordingly, we investigated the hypothesis that application of an endothelial cell (EC)-specific mitogen to a freshly denuded intimal surface could accelerate reendothelialization and thereby attenuate intimal hyperplasia. Methods and Results The left carotid artery of 31 Sprague-Dawley rats was subjected to balloon injury, after which 16 rats were treated with a 30-minute incubation with 100 mu g of vascular endothelial growth factor (VEGF), an EC-specific mitogen. Control animals (n=15) received a 30-minute incubation with 0.9% saline. At 2 weeks after balloon injury, carotid artery reendothelialization was markedly superior in the VEGF-treated group compared with the control group (14.59+/-1.12 versus 7.96+/-0.51 mm(2), P<.0005). The extent of reendothelialization measured at 4 weeks after balloon injury remained superior for arteries treated with VEGF (18.04+/-0.90 mm(2)) versus saline (13.42+/-0.84 mm(2), P<.005). Neointimal thickening was correspondingly attenuated to a statistically significant degree in arteries treated with VEGF versus the control group at both the 2-week and 4-week time points. Immunostaining for proliferating cell nuclear antigen (PCNA) disclosed a threefold increase in PCNA-positive cells in the neointima of control arteries versus VEGF-treated arteries at 2 weeks after injury. Conclusions Application of VEGF, an EC-specific growth regulatory molecule, may be effectively used in vivo to promote reendothelialization and thereby indirectly attenuate neointimal thickening due to SMC proliferation.
引用
收藏
页码:2793 / 2801
页数:9
相关论文
共 53 条
[1]   ANGIOGENIC-INDUCED ENHANCEMENT OF COLLATERAL BLOOD-FLOW TO ISCHEMIC MYOCARDIUM BY VASCULAR ENDOTHELIAL GROWTH-FACTOR IN DOGS [J].
BANAI, S ;
JAKLITSCH, MT ;
SHOU, M ;
LAZAROUS, DF ;
SCHEINOWITZ, M ;
BIRO, S ;
EPSTEIN, SE ;
UNGER, EF .
CIRCULATION, 1994, 89 (05) :2183-2189
[2]   SITE-SPECIFIC THERAPEUTIC ANGIOGENESIS AFTER SYSTEMIC ADMINISTRATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
BAUTERS, C ;
ASAHARA, T ;
ZHENG, LP ;
TAKESHITA, S ;
BUNTING, S ;
FERRARA, N ;
SYMES, JF ;
ISNER, JM .
JOURNAL OF VASCULAR SURGERY, 1995, 21 (02) :314-325
[3]  
BAUTERS C, 1994, AM J PHYSIOL, V36, pH1263
[4]  
Berinyi L K, 1992, J Vasc Surg, V15, P932
[5]   ARTERIAL REPAIR AND ATHEROSCLEROSIS AFTER MECHANICAL INJURY .5. TISSUE RESPONSE AFTER INDUCTION OF A LARGE SUPERFICIAL TRANSVERSE INJURY [J].
BJORKERUD, S ;
BONDJERS, G .
ATHEROSCLEROSIS, 1973, 18 (02) :235-255
[6]   ACIDIC FIBROBLAST GROWTH-FACTOR PROMOTES VASCULAR REPAIR [J].
BJORNSSON, TD ;
DRYJSKI, M ;
TLUCZEK, J ;
MENNIE, R ;
RONAN, J ;
MELLIN, TN ;
THOMAS, KA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8651-8655
[7]   RAPID DEVELOPMENT OF ATHEROSCLEROTIC LESIONS IN THE RABBIT CAROTID-ARTERY INDUCED BY PERIVASCULAR MANIPULATION [J].
BOOTH, RFG ;
MARTIN, JF ;
HONEY, AC ;
HASSALL, DG ;
BEESLEY, JE ;
MONCADA, S .
ATHEROSCLEROSIS, 1989, 76 (2-3) :257-268
[8]   VASCULAR-PERMEABILITY FACTOR - A TUMOR-DERIVED POLYPEPTIDE THAT INDUCES ENDOTHELIAL-CELL AND MONOCYTE PROCOAGULANT ACTIVITY, AND PROMOTES MONOCYTE MIGRATION [J].
CLAUSS, M ;
GERLACH, M ;
GERLACH, H ;
BRETT, J ;
WANG, F ;
FAMILLETTI, PC ;
PAN, YCE ;
OLANDER, JV ;
CONNOLLY, DT ;
STERN, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06) :1535-1545
[9]  
CLOWES AW, 1978, LAB INVEST, V39, P141
[10]  
CLOWES AW, 1985, AM J PATHOL, V118, P43